Important safety considerations include monitoring for signs of pancreatitis (severe abdominal pain radiating to the back), gallbladder disease, and hypoglycemia, particularly in patients taking concurrent diabetes medications
comparable to tirzepatide.[3][42] Common Side Effects : Nausea, vomiting, diarrhea, constipation (45-60% at higher doses)
If the latter, then any strain might not appear in GLP-1 supply itself, but could instead become apparent elsewhere in the portfolio
Management typically includes increasing intake of B12-rich foods, using high-quality B12 supplements, and in some cases receiving B12 injections prescribed by a healthcare provider
Oral semaglutide for weight loss in non diabetics is also feasible, without needing a diabetes diagnosis